Proposed SPC waiver has to go all the way

Tangible proposals for a waiver allowing manufacturing during the term of a supplementary protection certificate (SPC) have been announced by the European Commission, in a move that has been welcomed by off-patent industry association Medicines for Europe. However, the industry group cautions, such a mechanism must allow for both manufacturing for export and stockpiling for European launch upon SPC expiry to be truly effective and workable.